Shareholder Information

ExpreS2ion Biotechnologies have been listed on NASDAQ First North [EXPRS2] since 2016

Name Number of shares held Share of votes and capital
ExpreS2ion Holding ApS1 1.744.370 10,83%
AR Consult ApS2 1.327.003 8,24%
Summary shareholders over 5% 3.071.373 19,07%
Remaining shareholders (below 5%) 13.031.161 80,93%
Total 30/06/2020 16.102.534 100,00%

1. As of 30/06/2020, Co-Founder & Chairman of the board Martin Roland Jensen holds 32.22% of the voting and capital shares in ExpreS2ion Holding ApS. Co-Founder & COO Charlotte Dyring owns 39.23% of the voting and capital shares in ExpreS2ion Holding ApS. Co-Founder & CSO Wian de Jongh owns 28.55% of the voting and capital shares in ExpreS2ion Holding ApS.

2. Board member Allan Rosetzsky owns 100% of the shares in AR Consult ApS.

Certified Advisor

Svensk Kapitalmarknadsgranskning AB

Email: ca@skmg.se

Phone: +46 11 32 30 732

Web: www.skmg.se